MMedication Read More FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA24 December 2025 Approval of YARTEMLEA was based on results from a single-arm, open-label study in adults with TA-TMA (the TA-TMA…
